Zobrazeno 11 - 20
of 25
pro vyhledávání: '"556"'
Autor:
Christian U. Blank, Michal Lotem, Clemens Krepler, Teresa M. Petrella, Matteo S. Carlino, Caroline Robert, Georgina V. Long, Paul Lorigan, Antoni Ribas, James Larkin, Omid Hamid, Laurent Mortier, Jean-Jacques Grob, James R. Anderson, Catriona M. McNeil, Scott J. Diede, Bart Neyns, Ana Arance, Jacob Schachter, Adil Daud
Publikováno v:
Cancer Research. 79:CT188-CT188
Introduction: Pembro significantly improved OS vs ipi in advanced melanoma in the KEYNOTE-006 study (NCT01866319). We present outcomes from the 5-year follow-up of this study−the longest to date in a randomized phase 3 trial of pembro in advanced c
Publikováno v:
Cancer Research. 79:CT176-CT176
Background: Tumor Treating Fields (TTFields) are a non-invasive, regional antimitotic treatment modality, which has been approved for the treatment of patients with glioblastoma by the FDA. TTFields predominantly act by disrupting the formation of th
Publikováno v:
Cancer Research. 73:PD2-7
Background. Recreational exercise has been associated with a reduced risk of breast cancer, but evidence regarding breast cancer among African American women and about breast cancer subtypes is sparse. Methods. We assessed lifetime vigorous exercise
Autor:
Giampaolo Bianchini, L. Gianni, William Fraser Symmans, Milvia Zambetti, Takayuki Iwamoto, L Pusztai, Catherine M. Kelly, G Del Conte, Libero Santarpia, Angelica Fasolo
Publikováno v:
Cancer Research. 71:S1-7
Background Used upfront or after 2 to 3 years (yrs) of tamoxifen (TAM) or as extended treatment after 5 yrs of TAM, aromatase inhibitors (AIs) are associated with less recurrences than with 5 yrs of TAM. However, up front AIs were not superior to TAM
Autor:
I Bedrosian, DZ L'Heureux, Y-Ct Shih, Christopher Comstock, VJ Suman, Twf Yen, Constantine Gatsonis, K Yao, E Kim, R Birdwell, Gillian M. Newstead
Publikováno v:
Cancer Research. 71:OT2-05
Background Surgical planning and local-regional treatment of breast cancer relies on accurate assessment of disease extent including the primary tumor size and the presence/absence of multiple tumor foci. As a staging modality for breast cancer, MRI
Publikováno v:
Cancer Research. 78:CT157-CT157
Tumor Treating Fields (TTFields) are a non-invasive, regional antimitotic treatment modality, which has been approved for the treatment of patients with glioblastoma by the FDA. TTFields predominantly act by disrupting the formation of the mitotic sp
Publikováno v:
Cancer Research. 78:1565-1565
Background: Retinoblastoma (RB) is the most common pediatric retinal tumor initiated by biallelic inactivation of the retinoblastoma gene (RB1). Currently, chemotherapy with carboplatin, vincristine, and etoposide followed by optic enucleation is the
Autor:
Beata Peplonska, Jolanta Lissowska, Patricia Hartge, Sally B. Coburn, Britton Trabert, Michael Pawlita, Nicolas Wentzensen, Louise A. Brinton, Mark E. Sherman, Tim Waterboer
Publikováno v:
Cancer Research. 78:4942-4942
Background: Pelvic inflammatory disease (PID) has been associated with ovarian cancer and Chlamydia trachomatis (chlamydia) is the leading cause of PID in the developed world. Primary infection with chlamydia is often asymptomatic and may persist for
Autor:
Malgorzata A. Komor, Linda J. Bosch, Gergana Bounova, Anne S. Bolijn, Pien Delis-van Diemen, Christian Rausch, Youri Hoogstrate, Andrew Stubbs, Mark de Jong, Guido Jenster, Nicole C. an Grieken, Beatriz Carvalho, Lodewyk Wessels, Connie R. Jimenez, Remond J. Fijneman, Gerrit A. Meijer, NGS-ProToCol Consortium
Publikováno v:
Cancer Research. 78:3676-3676
Background Consensus molecular subtyping (CMS) is an RNA-expression-based classification of colorectal cancers (CRC). Genomic alterations, resulting in specific RNA-expression patterns, accumulate during CRC pathogenesis, including the premalignant a
Autor:
Zhiyong Liang, Yanna Zhang, S You, Jianning Zhang, Xiang Zhang, Jinghong Guan, Ying Zhong, R Yao, Xiang Wang, Yue Jiang, Jufang Shi, Q Zhu, Qiang Sun, Yidong Zhou, Q Xu, Ying Lin, Yong Xu, Songjie Shen, Feng Mao, B Pan
Publikováno v:
Cancer Research. 77:P5-02
Background: Milestone studies showed that ultrasound (US) was an effective primary screening test for breast cancer both in the western world and in China [PMID: 26712110, 26715161, and 25668012]. Ultrasound has been officially designated to be the i